Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Herceptin gives disappointing results in lung cancer trial

Herceptin gives disappointing results in lung cancer trial

January 08, 2004

Trastuzumab (Herceptin) - a treatment that has increased survival in many breast cancer patients - has failed to live up to hopes that it might also help lung cancer patients.

In a Phase II trial of over 100 patients with non-small-cell lung cancer (NSCLC) reported today (Tuesday 13 January) in Annals of Oncology[1], those treated with trastuzumab in combination with two chemotherapy agents gemcitabine and cisplatin, did no better than patients treated with gemcitabine and cisplatin alone.




There was a hint in the results that there could be a very small subgroup of lung cancer patients who may benefit. These are patients with extremely strong over-expression or amplification of HER2 - the gene that trastuzumab targets[2]. The international research team[3] believes that any future trials should focus on patients with high levels of HER2 over-expression or gene amplification. However, studies on those with the strongest possible over-expression or amplification will be difficult to carry out because the numbers of eligible patients will be small.

Lead researcher, Dr Ulrich Gatzemeier, Head of the Department of Thoracic Oncology, Zentrum für Pneumologie und Thoraxchirurgie, Krankenhaus Grosshansdorf, Germany, said that trastuzumab, combined with chemotherapy, had already shown major clinical benefit in women with HER2 positive breast cancer, including a significant increase in survival. As cell-line studies on HER2 positive NSCLC had shown that trastuzumab had an even greater synergy with gemcitabine and cisplatin than it had in breast cancer cells there was a rationale for believing that it might also benefit lung cancer patients.

"It was disappointing therefore to find that the survival times and the time to the disease progressing were very similar - between six and seven months for both the trastuzumab and control arms. However, we did find that the trastuzumab/chemotherapy combination was well tolerated and that five out of the six patients with extremely high levels of HER2 responded better than other HER2 patients. It was nearly eight and half months before their disease progressed compared with just over six months for the patients with less high HER2 levels. Unfortunately, this extremely high HER2 group made up less than two per cent of all the 619 patients we originally screened for trial eligibility and our data suggest that although nearly 60 per cent of NSCLC patients overall are HER2 positive any possible benefit of trastuzumab is likely to be confined to under five per cent of all patients with advanced NSCLC. That's only about 1,200 people per year in Germany. This makes future recruitment to clinical trials problematic and means that the likely clinical use of trastuzumab for NSCLC will be limited."

Dr Gatzemeier said that ongoing trials with other chemotherapy combinations might further define trastuzumab's potential use in NSCLC. But, it was important that any new trials focused on patients with high HER2 over-expression or amplification.

The main reason for the failure, according to Dr Gatzemeier, was that the majority of patients had lower levels (1+ and 2+) of high HER2 over-expression. Trastuzumab added nothing to an effective chemotherapy like cisplatin/gemcitabine - in accordance with other trials (INTACT, TALENT AND TRIBUTE) in which the aim was to inhibit receptors of epidermal growth factors. It was also possible that blocking only one of the growth factors was ineffective in NSCLC while there were parallel signalling pathways allowing the cancer to progress.
(ends)

[1]Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer. Annals of Oncology 15: 19-27.
[2]Trastuzumab (Herceptin) is a humanized monoclonal antibody rationally developed to target HER2 over-expressing cells. It has an additive or synergistic activity in combination with various cytotoxic chemotherapy in pre-clinical studies of breast cancer and NSCLC and is an effective new treatment in HER2 positive breast cancer.
[3]The trial involved an international team of researchers from Germany, Canada, the Netherlands, Italy and the UK, plus Roche Products Ltd., manufacturers of Herceptin.

MW Communications



Related Breast Cancer Current Events and Breast Cancer News Articles Breast Cancer Current Events and Breast Cancer News RSS Breast Cancer Current Events and Breast Cancer News RSS
Menopause-cardiology consensus statement on cardiovascular disease and on HRT
A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT.

Researchers Identify Role of Gene in Tumor Development, Growth and Progression
Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis.

UCLA researchers create 'fly paper' to capture circulating cancer cells
Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor.

Fertility procedures need not delay breast cancer treatment for younger women
A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion.

Coffee break: Compound brewing new research in colon, breast cancer
A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists.

Drugs to treat anemia in cancer patients linked to thromboembolism
Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center.

Discovery in worms by Queen's researchers points to more targeted cancer treatment
Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment.

FDA approved leukemia drugs shows promise in ovarian cancer cells
The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found.

Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe
The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated.

Scientists uncover new key to the puzzle of hormone therapy and breast cancer
The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer.
More Breast Cancer Current Events and Breast Cancer News Articles
New Balance Women's Lace Up X Out Breast Cancer Tech Tee (Athletic Grey, Small)

New Balance Women's Lace Up X Out Breast Cancer Tech Tee (Athletic Grey, Small)
by New Balance

The New Balance X Out Breast Caner Tee has a soft hand and clearly states how everyone feels!

Breast Cancer Survival Manual, Fourth Edition: A Step-by-Step Guide for the Woman With Newly Diagnosed Breast Cancer

Breast Cancer Survival Manual, Fourth Edition: A Step-by-Step Guide for the Woman With Newly Diagnosed Breast Cancer
by John Link (Author)

A completely updated edition of the definitive guide for patients with breast cancer
The new fourth edition of The Breast Cancer Survival Manual provides essential updates on treatment and care, enhancing the basic information that has made this the most trusted guide for women diagnosed with breast cancer for the past decade. This edition includes the most current advice on • getting a second opinion: why it’s important, what questions    to ask, and how to decide which team of doctors is best for you
• updates on genetic testing and how doctors are using
   the results to tailor care for each patient
• navigating new types of radiation, the herceptin
   breakthrough, and improved reconstruction surgeries
Conscious of the rapidly evolving spectrum of...

1149 WOMENS VINTAGE BLACK ADJUSTABLE FATIGUE CAP w/PINK STRIPES & ''BREAST CANCER'' RIBBON

1149 WOMENS VINTAGE BLACK ADJUSTABLE FATIGUE CAP w/PINK STRIPES & ''BREAST CANCER'' RIBBON
by Rothco

A portion of these proceeds go to the Babylon Breast Cancer Coalition- For Life, For Hope, For Change, For the Future Visit www.babylonbreastcancer.org for more information.

Sunbeam SlumberRest Camelot Microplush Heated Throw, Breast Cancer Awareness Pink

Sunbeam SlumberRest Camelot Microplush Heated Throw, Breast Cancer Awareness Pink
by Sunbeam

Soft comfortable fabric that you can cuddle up with anywhere in your house. Use it on the couch while curling up to read a good book or in a chair while watching your favorite show. This throw is 50"x60", with a primstyle control which features 3 warming settings and 3 hour auto-off. So turn on your warming blanket, turn off your thermostat and save on your heating bill. Warm up to a good cause! Sunbeam is joining the fight against breast cancer. Through the purchase of this pink throw, sunbeam will donate $1.00 to city of hope for breast cancer research, treatment and education* up to $25,000. Program ends april 30, 2009. "to save lives and end breast cancer forever by empowering people, ensuring quality care for all, and energizing science to find the cures." *to learn more about...

Hope Courage Strength Pink Ribbon Breast Cancer Awareness Expressively Yours Bracelet

Hope Courage Strength Pink Ribbon Breast Cancer Awareness Expressively Yours Bracelet
by MyJewelThief



Wrangler Women's Tough Enough To Wear Pink Breast Cancer Awareness Jacket,Pink,X-Large

Wrangler Women's Tough Enough To Wear Pink Breast Cancer Awareness Jacket,Pink,X-Large
by Wrangler

Are you tough enough to wear pink? That is the question the western industry asked 12/9/05 at the Wrangler National Finals Rodeo (Wrangler NFR), the "Super Bowl of pro rodeo," as it launched Tough Enough to Wear Pink (TETWP). TETWP is a multi-year, western-industry-wide fundraiser to raise awareness and funds for breast cancer research. TETWP partners are ponying up to support this cause by manufacturing pink merchandise with proceeds benefiting breast cancer research. By wearing this Tough Enough to Wear Pink shirt you are helping in the fight against breast cancer. This TETWP shirt is a pink cotton plaid. Import. Tough Enough to Wear Pink. long sleeve zip front jacket with zippered front slash pockets and the breast cancer embroidery on left chest. 100% Polyester Fleece/100% Nylon...

Raymond Geddes National Breast Cancer Foundation Pen (67709)

Raymond Geddes National Breast Cancer Foundation Pen (67709)
by Raymond Geddes

Breast Cancer Awareness Pen, Join Geddes in supporting the National Breast Cancer Foundation and the fight against Breast Cancer. Assortment contains pink pens with pink ribbons. Retractable, black in pen ink. 5 1/2" long.

Just Get Me Through This!: The Practical Guide to Breast Cancer

Just Get Me Through This!: The Practical Guide to Breast Cancer
by Deborah A. Cohen (Author), M.D., Robert M. Gelfand (Author)



Find the Cure Pink Breast Cancer Awareness Wristband

Find the Cure Pink Breast Cancer Awareness Wristband
by sci

Find The Cure Pink Breast Cancer Awareness wristband

Fox Run Breast Cancer Awareness Baking Set

Fox Run Breast Cancer Awareness Baking Set
by Fox Run

Support Breast Cancer awareness in a sweet way with this five piece set. Bake cookies using the ribbon cookie cutters or cupcakes using the white paper bake cups with the pattern of pink ribbons. Decorate both with the included 4 in 1 sprinke assortement jar. The set also includes a pink silicone spoon spatula to help mix up your favorite batch of cookie dough.

© 2009 BrightSurf.com